Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma

Author： Nakaoka Toshiaki   Saito Yoshimasa   Saito Hidetsugu  

Publisher： MDPI

E-ISSN： 1422-0067|18|6|1111-1111

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.18, Iss.6, 2017-05, pp. : 1111-1111

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aberrant DNA Methylation of rDNA and PRIMA1 in Borderline Personality Disorder

By Teschler Stefanie   Gotthardt Julia   Dammann Gerhard   Dammann Reinhard H.  

International Journal of Molecular Sciences, Vol. 17, Iss. 1, 2016-01 ,pp. : 67-67

MDPI

Access to resources Recommend Favorite

Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer

By Pyragius Carmen E.   Fuller Maria   Ricciardelli Carmela   Oehler Martin K.  

International Journal of Molecular Sciences, Vol. 14, Iss. 4, 2013-04 ,pp. : 7742-7756

MDPI

Access to resources Recommend Favorite

Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target

By Yee Nelson S.  

Pharmaceuticals, Vol. 10, Iss. 2, 2017-04 ,pp. : 39-39

MDPI

Access to resources Recommend Favorite

MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer

By Chou Chen-Kai   Liu Rue-Tsuan   Kang Hong-Yo  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 636-636

MDPI

Access to resources Recommend Favorite

DNA Methylation and Cancer Diagnosis

By Delpu Yannick   Cordelier Pierre   Cho William C.   Torrisani Jérôme  

International Journal of Molecular Sciences, Vol. 14, Iss. 7, 2013-07 ,pp. : 15029-15058

MDPI

Access to resources Recommend Favorite